Hook & thesis
Palantir has been a poster child for the AI growth trade: rapid revenue acceleration, sky-high margins and a market cap that presumes a lot of perfection. That reality shows up in the multiples — today the stock trades well north of 100x earnings. That makes buying into strength risky. I want to buy Palantir, but only once the market rewards some of the risk with a lower entry valuation. This is a tactical, valuation-driven idea: enter at the dip where Palantir trades around 93x trailing earnings (entry = $88.35), manage risk with a strict $72.00 stop, and target $150.00 over a 180-trading-day window.
Why 93x? It’s a compromise between paying today’s frothy multiples and missing out if the company continues to execute. At $88.35 the stock still prices in growth, but offers a more defensible risk/reward while leaving room for multiple expansion if revenue and earnings continue to accelerate.
Business snapshot - why the market should care
Palantir builds enterprise-grade data and analytics platforms used across government and commercial customers. Its platforms are positioned as operational control systems for complex organizations — think defense, intelligence, healthcare, energy and financial services — where integrating messy data and powering operational decisions has real dollar impact. The business has moved from government-heavy revenues toward a bigger commercial footprint, which is the core reason investors peg a high multiple to the stock.
What the numbers say
- Revenue and growth: Palantir reported roughly $4.5B in revenue with 56.2% year-over-year growth. That’s a rate you typically see in high-growth software names.
- Profitability: Net income of about $1.6B and reported profit margins north of 50% indicate the company is already converting growth into substantial profits.
- Cash flow and balance sheet: Free cash flow is meaningful at roughly $2.69B, and liquidity metrics are healthy with a current and quick ratio around 6.91. Reported cash on the balance sheet is about $1.66B.
- Valuation snapshot: Market cap sits near $318B. Trailing multiples are elevated — P/E north of 140x depending on the snapshot you use — which is the central tension for this trade.
The practical takeaway: Palantir has many of the attributes growth investors want — strong revenue acceleration, superior margins and chunky free cash flow. The trade is about buying those attributes at a price that reduces downside risk.
Valuation framing - why wait for the dip
At today's prices investors are paying for near-perfect execution and multiple expansion. That can work, but it leaves little room for execution slips, macro rotation or broader market de-risking. Moving the entry valuation from ~140-150x down to 93x trailing earnings accomplishes two things: it lowers your breakeven let’s earnings growth do more of the heavy lifting, and it limits downside if the market slams growth multiples again.
To be explicit: using trailing EPS near $0.95, a 93x multiple implies a price of about $88.35. That’s the level where the market still grants Palantir a premium for growth but doesn’t demand near-flawless execution to justify the entry. If Palantir grows EPS by ~50% over the next year (a pace some analysts expect), a multiple re-rate back toward 100x would comfortably support the higher-target price I set below.
Trade plan (actionable)
| Action | Price | Horizon |
|---|---|---|
| Entry - Buy the dip | $88.35 | Long term (180 trading days) - allow earnings growth and re-rating to play out |
| Stop loss - Protect capital | $72.00 | |
| Target - Partial exit | $150.00 |
Horizon rationale: I peg this as a long-term swing meant to give Palantir time to translate accelerating revenue into higher EPS and investor confidence. The company’s fundamentals and free cash flow suggest earnings upside; a 180-trading-day window gives execution, contract cadence and multiple repricing time to materialize.
Catalysts
- Continued commercial expansion and large enterprise deal announcements that demonstrate sticky, recurring revenue outside government.
- Quarterly results that beat revenue and EPS expectations and show sequential margin improvement, allowing the market to justify higher multiples.
- New product traction in the agentic AI market that materially increases average revenue per customer or shortens sales cycles.
- Analyst upgrades and increased sell-side conviction — there are already shoutings of 50%+ earnings growth, and more positive revisions would help.
Technical & market structure context
The chart shows the stock below multiple short-term moving averages (10/20/50-day SMAs) and the RSI around 41, which is neither deeply oversold nor bullishly extended. MACD readings show early bullish momentum emerging, and short interest is modest relative to float with days-to-cover near ~1.4 — suggesting squeezes are possible but not the primary driver. In short, the technical picture is neutral-to-favorable once the valuation gap is addressed.
Risks & counterarguments
Below are the main risks that could derail this trade:
- Valuation risk - Even at $88.35, Palantir trades at a premium relative to many mature software peers. If the AI hype cycle cools, the multiple could compress further.
- Execution risk - Slower-than-expected commercial adoption or elongated sales cycles would hit revenue and margin trajectories, making re-rating less likely.
- Macro / liquidity risk - A broader market sell-off or rising rates that punish long-duration growth stocks could push the stock well below the $72 stop.
- Customer concentration and political risk - The company's legacy government exposure and sensitivity to defense spending (and related regulatory scrutiny) add idiosyncratic risk.
- Multiple tail-risk - Analysts and the market currently expect steep earnings growth; if growth decelerates materially, the multiple could fall faster than earnings improve.
Counterargument: The main bear case is valuation — critics point out that the stock already carries a P/E above 140x and that paying for future optionality is dangerous. That’s fair; the counter to that is Palantir’s current earnings, margins and free cash flow show it can already monetize a large part of its platform. If earnings expand at the historical/expected rates and the commercial pivot continues, the company can justify a higher absolute valuation in dollar terms even if multiples moderate. That is why I require the valuation buffer and make entry conditional on the dip to ~93x.
What would change my mind
I would walk away from this idea if any of the following occur: a) guidance or Qs indicate a sustained slowdown in commercial bookings or materially lower bookings visibility; b) free cash flow turns negative or deteriorates substantially; c) the company loses several large commercial clients or there is public evidence that competitors are taking share in Palantir’s core enterprise verticals; d) macro conditions make growth multiples generally unattractive (e.g., a sustained, broad-based re-rating of the high-growth cohort where Palantir is lumped in).
Conclusion
Palantir is an offensive growth name with real, demonstrable economics. The problem today is price: the market is pricing near-perfection. This trade idea marries respect for the business with discipline on valuation. Buying at $88.35 (about 93x trailing earnings) gives a more favorable risk/reward than buying at current prices while still paying for growth. Use a hard stop at $72.00, target $150.00 over roughly 180 trading days, and be ready to trim if earnings momentum or macro sentiment shifts.
Execution note: if the stock approaches the entry level, scale in size to avoid emotional entry and treat any partial fills as opportunities to average down only if the underlying fundamentals remain on track.
Trade idea summary - Entry: $88.35 | Stop: $72.00 | Target: $150.00 | Horizon: Long term (180 trading days) | Risk: High